Suchergebnisse - "Cho, Jung-Eun"

PubPharm (32)

1

Real-World Safety and Effectiveness of Fluticasone Furoate/Vilanterol in Patients with Asthma and/or Chronic Obstructive Pulmonary Disease : A Post-Marketing Study in Korea

enthalten in: Drug safety | 2023

von Cho, E. | Cho, J. | Jang, S. | +1

2

A Korean Post-Marketing Study of Abacavir/Dolutegravir/Lamivudine in Patients with HIV-1

enthalten in: Infection & chemotherapy | 2023

von Shin, S. | Cho, J. | Lee, E. | +2

CommentIn: Infect Chemother. 2024 Mar;56(1):96-97. - PMID 38527777

3

Real-World Safety and Effectiveness of Fluticasone Furoate/Vilanterol in Patients with Asthma and/or Chronic Obstructive Pulmonary Disease: A Post-Marketing Study in Korea

enthalten in: Drug safety | 2023

von Cho, E. | Cho, J. | Jang, S. | +1

4

Novel SARS-CoV-2 entry inhibitors, 2-anilinoquinazolin-4(3H)-one derivatives, show potency as SARS-CoV-2 antivirals in a human ACE2 transgenic mouse model

enthalten in: Journal of medical virology | 2023

von Ko, M. | Lee, J. | Shin, Y. | +9

5

An Open-Label, Multicentre, Observational, Post-Marketing Study to Monitor the Safety and Effectiveness of Umeclidinium/Vilanterol in Korean Patients

enthalten in: Tuberculosis and respiratory diseases | 2023

von Cho, E. | Cho, J. | Lee, E. | +2

6

Novel SARS‐CoV‐2 entry inhibitors, 2‐anilinoquinazolin‐4(3 H)‐one derivatives, show potency as SARS‐CoV‐2 antivirals in a human ACE2 transgenic mouse model

enthalten in: Journal of Medical Virology | 2023

von Ko, M. | Lee, J. | Shin, Y. | +9

7

A Korean Post-Marketing Surveillance Study of Dolutegravir Single-Agent Tablets in Patients with HIV-1

enthalten in: Infection & chemotherapy | 2022

von Kwon, S. | Cho, J. | Lee, E. | +2

8

Identification of 3-Oxindole Derivatives as Small Molecule HIV-1 Inhibitors Targeting Tat-Mediated Viral Transcription

enthalten in: Molecules (Basel, Switzerland) | 2022

von Kim, D. | Shin, Y. | Cho, J. | +5

9

Optimization of 2-Aminoquinazolin-4-(3H)-one Derivatives as Potent Inhibitors of SARS-CoV-2 : Improved Synthesis and Pharmacokinetic Properties

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2022

von Shin, Y. | Lee, J. | Jeon, S. | +9

10

Synthesis and biological evaluation of 2-benzylaminoquinazolin-4(3H)-one derivatives as a potential treatment for SARS-CoV-2

enthalten in: Bulletin of the Korean Chemical Society | 2022

von Lee, J. | Shin, Y. | Jeon, S. | +8